Joshua Gordon
Optometrist · Ellicott City, MDNPI 1306877683
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,881 of the $7,985 with a category attached, or 73.7%. It is spread thinly across 25 manufacturers, the largest accounting for just 23.2%. Among optometrist clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 206 payments — averaging $38.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tarsus Pharmaceuticals, Inc.$2K
- Johnson & Johnson Vision Care, Inc.$2K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$846
- Alcon$667
- AbbVie$588
- Biotissue Holdings Inc.$570
- plus $2K from 19 others
What the payments were for
- Consulting fees$1,77722%
- Food & beverage$5,88174%
- Education$180%
- Entertainment$3094%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 29 | $1,855 |
| Johnson & Johnson Vision Care, Inc. | 42 | $1,743 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 19 | $846 |
| Alcon | 30 | $667 |
| AbbVie(2 entities) | 9 | $588 |
| Biotissue Holdings Inc. | 19 | $570 |
| Optos, Inc. | 10 | $309 |
| Heru, Inc. | 1 | $214 |
| Eyevance Pharmaceuticals LLC | 8 | $169 |
| Rxsight Inc | 2 | $157 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $145 |
| Sight Sciences, Inc. | 5 | $123 |
| Bausch & Lomb Americas Inc. | 6 | $118 |
| Shire North American Group Inc | 2 | $81 |
| Quidel Corporation | 2 | $55 |
| Amgen | 2 | $49 |
| Kala Pharmaceuticals, Inc. | 2 | $45 |
| ABB Con-cise Optical Group LLC | 2 | $44 |
| Harrow Eye, LLC | 2 | $42 |
| Sun Pharmaceutical Industries Inc. | 2 | $40 |
| Glaukos Corporation | 2 | $40 |
| Thea Pharma Inc. | 2 | $35 |
| Aerie Pharmaceuticals, Inc. | 1 | $19 |
| Dompe US, Inc. | 1 | $17 |
| Alcon Research LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XDEMVY$1,143
- BIOTRUE ONE DAY$242
- Acuvue$225
- Heru HMD$214
- Prokera$164
- AmnioGraft$164
- DURYSTA$125
- RXSIGHT CONTACT LENS$110
- RXSIGHT INJECTOR CARTRIDGE$110
- RXSIGHT INJECTOR HANDPIECE$110
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$110
- LIGHT ADJUSTABLE LENS (LAL)$110
- BTOD$107
How this compares
$7,985 in reported general payments places this provider in the 95th percentile of 790 optometrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XdemvyLotilaner | 46 | $85,366 |
| RestasisCyclosporine | 12 | $8,996 |
| Prednisolone Acetate | 25 | $737 |
| Latanoprost | 48 | $345 |
| Timolol Maleate | 20 | $69 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Tarsus Pharmaceuticals, Inc.Xdemvy | $1,855 | $85,36646 claims |
| AbbVieRestasis | $588 | $8,99612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 790 optometrist providers in Maryland.
Other optometrist in Ellicott City
- Rizwana IqbalEllicott City$34K
- Susan LathropFulton$337K
- Timothy EarleyOakland$276K
- Padmini NathanFrederick$199K
- Alan GlazierRockville$87K
- Andrew MorgensternBethesda$62K
- Devin SasserSilver Spring$40K
- Brian WoolfPasadena$19K
- Vickie FangGaithersburg$17K
- Aaron WeinsteinWaldorf$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.